ATP-binding cassette sub-family a member1 gene mutation improves lipid metabolic abnormalities in diabetes mellitus
Tóm tắt
Patients with diabetes mellitus were often accompanied with hyperlipidemia. ATP-binding cassette sub-family A member1 (ABCA1) promotes the efflux of lipids and thereby mediates the metabolism of cholesterol. The aim of our study was to determine the associations of ABCA1 gene polymorphisms with the risks of diabetes mellitus and dyslipidemia in diabetic patients. We retrieved literature about the relationship between ABCA1 gene polymorphisms (C69T and R230C) and the risk of diabetes through PubMed, Web of Science, EMBASE, Wanfang Database, China National Knowledge Infrastructure (CNKI) and Cochrane database. Weighted mean difference (WMD) and odds ratio (OR) were used to compare continuous and dichotomous variables, respectively, accompanied by their 95% confidence interval (CI). A total of 1746 diabetic patients and 1292 non-diabetic controls were enrolled. All subjects were Caucasians. ABCA1 R230C T allele was significantly associated with reduced the risk of diabetes (OR = 0.75, 95% CI = 0.57–0.98, P = 0.04). There was no association of ABCA1 C69T gene polymorphisms with the risk of diabetes. However, subgroup analyses showed that the ABCA1 C69T gene mutation significantly reduced the risk of hypertriglyceridemia in diabetic patients as compared with that in non-diabetic subjects (dominant model: WMD =0.66, 95% CI = 0.52–0.8, P < 0.0001; recessive model: WMD = 0.47, 95%CI = 0.11–0.83, P = 0.01). ABCA1 R230C T allele gene mutation is a protective in decreasing the risk of diabetes in Caucasians and ABCA1 C69T gene mutation markedly influences the level of lipid metabolism in diabetic patients.
Tài liệu tham khảo
Zhang Z, Zhang X, Dong J, et al. Association of chemokine ligand 5/chemokine receptor 5 gene promoter polymorphisms with diabetic microvascular complications: a meta-analysis. J Diabetes Investig. 2016;7(2):212–8.
Villalpando S, de la Cruz V, Rojas R, et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Pública De Mexico. 2010;52(Suppl 1):S19–26.
Zhang ZW, Wu X, Cai T, Gao WY, Zhou XJ, Zhao JY, Yao JM, Shang HX, Dong JJ, Liao L. Matrix metalloproteinase 9 gene promoter polymorphisms (rs 34016235) reduce the risk of diabetic microvascular complications. Int J Environ Res Public Health. 2015;12:8023–33.
Shen X, Zhang ZW, Zhang X, et al. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2016;15(1):179.
Daimon M, Ji G, Saitoh T, et al. Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population. Biochem Biophys Res Commun. 2003;302(4):751–8.
Ergen HA, Zeybek U, Gök O, et al. Investıgatıon of ABCA1 C69T polymorphısm ın patıents wıth type 2 dıabetes mellıtus. Biochem Med (Zagreb). 2012;22(1):114–20.
Larariegos JC, Ortizlópez MG, Peñaespinoza BI, et al. Diabetes susceptibility in Mayas: evidence for the involvement of polymorphisms in HHEX, HNF4α, KCNJ11, PPARγ, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes. Gene. 2015;565(1):68–75.
Makoto D, Takashi K, Masanori B, et al. Association of the ABCA1 gene polymorphisms with type 2 DM in a Japanese population. Biochem Biophys Res Commun. 2008;365(3):466–71.
Rütti S, Ehses JA, Sibler RA, et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology. 2009;150(10):4521–30.
Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet. 2008;371(9626):1800–9.
Campbell DD, Parra MV, Duque C, et al. Amerind ancestry, socioeconomic status and the genetics of type 2 diabetes in a Colombian population. PLoS One. 2012;7(4):e33570.
Alharbi KK, Khan IA, Al-Daghri NM, et al. ABCA1 C69T gene polymorphism and risk of type 2 diabetes mellitus in a Saudi population. J Biosci. 2013;38(5):893–7.
Haghvirdizadeh P, Ramachandran V, Etemad A, et al. Association of ATPBinding Cassette Transporter A1 Gene Polymorphisms in Type 2 Diabetes Mellitus among Malaysians. J Diabetes Res. 2015;2015:289846.
Salinas CA, Cruz-Bautista I, Mehta R, et al. The ATP-binding cassette transporter subfamily A member 1 (ABC-A1) and type 2 diabetes: an association beyond HDL cholesterol. Curr Diabetes Rev. 2007;3(4):264–7.
Acuña-Alonzo V, Flores-Dorantes T, Janine K, et al. Kruit a functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in native Americans. Hum Mol Genet. 2010;19(14):2877–85.
Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367–77.
Kruit JK, Wijesekara N, Fox JEM, et al. Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules. Diabetes. 2011;60(12):3186–96.
Aguilar-Salinas CA, Canizales-Quinteros S, Rojas-Martínez R, et al. Hypoalphalipoproteinemia in populations of native American ancestry: an opportunity to assess the interaction of genes and the environment. Curr Opin Lipidol. 2009;20(2):92–7.
Mo XD, Gao LP, Wang QJ, et al. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo. Lipids Health Dis. 2018;17(1):42.
Villarrealmolina MT, Floresdorantes MT, Arellanocampos O, et al. Association of the ATP-binding cassette transporter A1 R230C variant with earlyonset type 2 diabetes in a Mexican population. Diabetes. 2008;57(2):509–13.
Kakehi S, Tamura Y, Takeno K, et al. Increased intramyocellular lipid/impaired insulin sensitivity is associated with altered lipid metabolic genes in muscle of high responders to a high fat diet. Am J Physiol Endocrinol Metab. 2016;310(1):E32–40.
Clee SM, Kastelein JJ, Van DM, et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest. 2000;106(10):1263–70.
Oram JF, Lawn RM. ABCA1: the gatekeeper for eliminating excess tissue cholesterol. J Lipid Res. 2001;42(8):1173–9.
Aron-Wisnewsky J, Julia Z, Poitou C, et al. Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women. J Clin Endocrinol Metab. 2011;96(4):1151–9.
Combes V, Coltel N, Alibert M, et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol. 2005;166(1):295–302.